Skip to main content
رجوع
Watch Compare

Aptose Biosciences Inc.

جودة البيانات: 83%
APTOF
OTC Manufacturing Chemicals
KWD 1.71
▲ KWD 0.03 (1.79%)
القيمة السوقية: 4.41 M
السعر
KWD 1.71
القيمة السوقية
4.41 M
نطاق اليوم
KWD 1.71 — KWD 1.73
نطاق 52 أسبوعًا
KWD 0.64 — KWD 2.50
حجم التداول
186
فتح KWD 1.71
متوسط 50 يوم / 200 يوم
KWD 1.63
4.83% above
متوسط 50 يوم / 200 يوم
KWD 1.43
19.76% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -21.99 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.53
Interest CoverageN/A

التقييم

PE (TTM)
-0.17
أعلى من متوسط القطاع (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -0.2 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -25.47 M
ROE N/A ROA -426.89%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -21.99 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.53
Interest Coverage N/A Asset Turnover N/A
Working Capital -3.30 M Tangible Book Value -19.45 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.17 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -498.66%
Market Cap 4.41 M Enterprise Value 3.80 M
Per Share
EPS (Diluted TTM) -10.41 Revenue / Share N/A
FCF / Share -8.53 OCF / Share -8.53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 86.34%
SBC-Adj. FCF -22.41 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -25.47 M -25.43 M -51.21 M -41.82 M -65.35 M
EPS (Diluted) -10.41 -36.38 -7.58 -0.45 —
Gross Profit — — — — —
Operating Income — — — — —
EBITDA — — — — —
R&D Expenses 11.34 M 15.10 M 33.27 M 28.09 M 45.99 M
SG&A Expenses — — — — —
D&A — — 88,000.0 120,000.0 150,000.0
Interest Expense — — — — —
Income Tax 0.0 0.0 — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.01 M 10.13 M 12.99 M 51.03 M 82.53 M
Total Liabilities 37.18 M 14.67 M 15.89 M 13.29 M 8.29 M
Shareholders' Equity -27.17 M -4.54 M -2.90 M 37.74 M 74.24 M
Total Debt — — — — —
Cash & Equivalents 935,000.0 6.15 M 9.25 M 36.97 M 39.11 M
Current Assets 6.45 M 9.53 M 11.89 M 49.52 M 81.74 M
Current Liabilities 9.31 M 4.46 M 15.27 M 12.28 M 8.17 M